home / stock / prld / prld short
Short Information | Prelude Therapeutics Incorporated (NASDAQ:PRLD)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 102,514 |
Total Actual Volume | 927,217 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 5,126 |
Average Short Percentage | 11.14% |
Is there a PRLD Short Squeeze or Breakout about to happen?
See the PRLD Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-26-2024 | $4.05 | $4.07 | $4.07 | $3.99 | 18,543 | 1,646 | 8.88% |
04-25-2024 | $3.99 | $4.04 | $4.09 | $3.99 | 115,746 | 8,200 | 7.08% |
04-24-2024 | $3.87 | $3.87 | $4.13 | $3.87 | 28,584 | 1,265 | 4.43% |
04-23-2024 | $3.89 | $3.87 | $4.07 | $3.87 | 24,900 | 4,282 | 17.2% |
04-22-2024 | $3.75 | $3.85 | $3.9643 | $3.75 | 50,051 | 4,787 | 9.56% |
04-19-2024 | $3.45 | $3.72 | $3.86 | $3.45 | 57,910 | 4,750 | 8.2% |
04-18-2024 | $4.16 | $3.44 | $4.18 | $3.42 | 112,889 | 8,745 | 7.75% |
04-17-2024 | $4.8 | $4.18 | $4.98 | $4.1 | 68,937 | 8,496 | 12.32% |
04-16-2024 | $5.63 | $4.91 | $5.63 | $4.79 | 38,381 | 1,428 | 3.72% |
04-15-2024 | $5.75 | $5.63 | $5.83 | $5.4164 | 89,987 | 12,311 | 13.68% |
04-12-2024 | $5.27 | $5.62 | $5.77 | $5.12 | 58,031 | 8,358 | 14.4% |
04-11-2024 | $4.94 | $5.22 | $5.35 | $4.855 | 45,170 | 9,377 | 20.76% |
04-10-2024 | $4.82 | $4.95 | $5.17 | $4.67 | 24,121 | 2,261 | 9.37% |
04-09-2024 | $4.69 | $4.99 | $5.07 | $4.56 | 64,215 | 14,352 | 22.35% |
04-08-2024 | $4.72 | $4.7 | $4.82 | $4.6 | 15,589 | 2,240 | 14.37% |
04-05-2024 | $4.67 | $4.7 | $4.98 | $4.47 | 17,673 | 1,807 | 10.22% |
04-04-2024 | $4.72 | $4.74 | $4.85 | $4.58 | 21,812 | 1,425 | 6.53% |
04-03-2024 | $4.52 | $4.72 | $4.755 | $4.52 | 28,329 | 3,122 | 11.02% |
04-02-2024 | $4.63 | $4.62 | $4.65 | $4.41 | 31,908 | 1,149 | 3.6% |
04-01-2024 | $4.76 | $4.69 | $4.93 | $4.6101 | 14,441 | 2,513 | 17.4% |
News, Short Squeeze, Breakout and More Instantly...
Prelude Therapeutics Incorporated Company Name:
PRLD Stock Symbol:
NASDAQ Market:
Highly selective oral SMARCA2 degrader, PRT7732, shows robust anti-tumor activity in vivo as monotherapy and in combination with chemotherapy, at ...
Highly selective oral SMARCA2 degrader, PRT7732, shows robust anti-tumor activity in vivo as monotherapy and in combination with chemotherapy, at well-tolerated doses Potentially best-in-class CDK9 inhibitor, PRT2527, in Phase 1 development, is highly effective in preclinical hematolo...
WILMINGTON, Del., March 05, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (NASDAQ:PRLD), a clinical-stage precision oncology compan...